These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2530529)

  • 1. [In vitro effect of cefixime against Haemophilus influenzae].
    Dabernat H; Delmas C
    Presse Med; 1989 Oct; 18(32):1551-2. PubMed ID: 2530529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.
    García-Cobos S; Campos J; Lázaro E; Román F; Cercenado E; García-Rey C; Pérez-Vázquez M; Oteo J; de Abajo F
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2564-73. PubMed ID: 17470649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients.
    Mortensen JE; Himes SL
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1456-8. PubMed ID: 2386375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
    Bergeron MG; Lavoie GY; Boucher FD
    J Antimicrob Chemother; 1987 Nov; 20(5):663-9. PubMed ID: 3501422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
    Barry AL; Fuchs PC; Pfaller MA
    Antimicrob Agents Chemother; 1993 Jan; 37(1):14-8. PubMed ID: 8431012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
    Doern GV
    Diagn Microbiol Infect Dis; 1991; 14(1):75-7. PubMed ID: 1901536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
    Williams JD; Powell M; Fah YS; Seymour A; Yuan M
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):748-51. PubMed ID: 1425737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of susceptibility of Haemophilus influenzae to beta-lactams by using HTM gelose (Haemophilus test medium)].
    Dabernat H; Seguy M; Delmas C
    Pathol Biol (Paris); 1993 Sep; 41(7):589-95. PubMed ID: 8255610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases.
    García-Cobos S; Arroyo M; Campos J; Pérez-Vázquez M; Aracil B; Cercenado E; Orden B; Lara N; Oteo J
    J Antimicrob Chemother; 2013 May; 68(5):1054-9. PubMed ID: 23335113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
    Perea EJ; Garcia Iglesias MC
    J Antimicrob Chemother; 1994 Jul; 34(1):161-4. PubMed ID: 7961203
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem.
    García-Cobos S; Arroyo M; Pérez-Vázquez M; Aracil B; Lara N; Oteo J; Cercenado E; Campos J
    J Antimicrob Chemother; 2014 Jan; 69(1):111-6. PubMed ID: 23943391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
    Stefani S; Pellegrino MB; D'Amico G; Privitera A; Privitera O; Maccarrone G; Russo G; Nicoletti G
    Chemotherapy; 1992; 38(1):36-45. PubMed ID: 1618002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surveillance of antimicrobial susceptibility of Haemophilus influenzae isolates from children in Beijing, Shanghai, and Guangzhou 2000 - 2002].
    Shen XZ; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Jiang M; Hu YY; Yang YH
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1335-9. PubMed ID: 15387940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients.
    Kumar A; Kelly KJ
    Chemotherapy; 1988; 34(1):30-5. PubMed ID: 3258232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents.
    Lehtonen L; Huovinen P
    Scand J Infect Dis; 1993; 25(3):373-8. PubMed ID: 8362234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
    Delmée M; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
    Acta Clin Belg; 1996; 51(4):237-43. PubMed ID: 8858889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
    Tremblay LD; L'Ecuyer J; Provencher P; Bergeron MG
    CMAJ; 1990 Nov; 143(9):895-901. PubMed ID: 2224717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae.
    Burns JL; Wong K; Smith AL
    Infection; 1988; 16(5):293-6. PubMed ID: 3265130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
    Liljequist BO; Gezelius L
    Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
    Alou L; Giménez MJ; Sevillano D; Aguilar L; González N; Echeverría O; Torrico M; Coronel P; Prieto J
    J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.